GM-CSF is widely used in clinical trials regarding cancer vaccines because of its effect on T-cell activation and proliferation and APC maturation, although there is evidence that it may promote myeloid-derived suppressor cells (MDSC) recruitment into the TME, tampering with the anti-tumor immune response (18). This evidence concerns the gene CSF2 and cancer.